The Bone Health Debate: Navigating the Complex Relationship Between GLP-1 Agonists and Skeletal Integrity
For millions of Americans living with obesity and type 2 diabetes, the emergence of glucagon-like peptide-1 (GLP-1) receptor agonists—marketed as Ozempic, Wegovy, Zepbound, and Mounjaro—has been nothing short of a…
